<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-30 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-30/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-30"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-30 ä»Šæ—¥ç­›é€‰å‡º 73 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-30T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-30T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week482025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-30"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-30 ä»Šæ—¥ç­›é€‰å‡º 73 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-30T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-30T00:00:00+00:00"><meta itemprop=wordCount content="2283"><meta itemprop=keywords content="Research,Daily,Week482025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-30"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-30 ä»Šæ—¥ç­›é€‰å‡º 73 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-30</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-30T00:00:00Z>2025-11-30</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-30>ğŸ“… Daily Report - 2025-11-30</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>73</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
å…¨æ–°ç»†èƒæ­»äº¡æ–¹å¼Mitoxyperilysisï¼ˆçº¿ç²’ä½“æ°§åŒ–é©±åŠ¨ï¼‰è¢«å‘ç°ï¼Œä¸ºç™Œç—‡æ²»ç–—æä¾›æ–°é¶ç‚¹ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å…ç–«é€ƒé€¸ä¸è€è¯ï¼šFAM114A1åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å…³é”®ä½œç”¨ï¼›C1QC+å·¨å™¬ç»†èƒ-CD4+ Tç»†èƒäº’ä½œï¼›å¹²æ‰°ç´ è¯±å¯¼çš„è¡°è€CD8Tç»†èƒå½±å“å…ç–«æ²»ç–—ï¼›é¶å‘DPP7+TAMsæé«˜å…ç–«æ²»ç–—ç–—æ•ˆï¼›åŸºè´¨ç»†èƒ-å…ç–«ç»†èƒäº’ä½œç½‘ç»œï¼›é¶å‘è‚¿ç˜¤é…¸ä¸­æ¯’ã€‚</li><li>è¡°è€ä¸ç–¾ç—…æœºåˆ¶ï¼šè¡°è€ä½œä¸ºèƒ¶è´¨æ¯ç»†èƒç˜¤é¢„åé£é™©å› ç´ ï¼›è¡°è€ä¸ç–¾ç—…æœºåˆ¶ç ”ç©¶ï¼ˆè¡€ç®¡å’Œç¥ç»ç±»å™¨å®˜æ¨¡å‹ï¼‰ã€‚</li><li>ç»†èƒæ­»äº¡ä¸ä»£è°¢ï¼šçº¿ç²’ä½“NAD+è°ƒæ§çº¿ç²’ä½“è‡ªå™¬åŠç‚ç—‡ååº”ï¼›æ°¨åŸºé…¸ä»£è°¢åœ¨ç™Œç—‡ç ”ç©¶ä¸­çš„åº”ç”¨ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç©ºé—´å¤šç»„å­¦æ­ç¤ºç»†èƒç”Ÿæ€ä½ã€‚</li><li>å¤šç»„å­¦ï¼ˆåŒ…æ‹¬è¡¨è§‚åŸºå› ç»„ï¼‰åˆ†æé©±åŠ¨è¯ç‰©è€è¯æ€§æœºåˆ¶ã€‚</li><li>å¹²æ¹¿ç»“åˆï¼ˆç”Ÿä¿¡ä¸å®éªŒéªŒè¯ï¼‰æ¨¡å¼å¹¿æ³›åº”ç”¨äºå¤šé¢†åŸŸç ”ç©¶ï¼Œå°¤å…¶åœ¨è¯†åˆ«å…³é”®åŸºå› ã€éªŒè¯æ¨¡å‹åŠç ”ç©¶é€šè·¯æ–¹é¢ã€‚</li><li>å•ç»†èƒRNAæµ‹åºçš„å¤§è§„æ¨¡åŸºå‡†æµ‹è¯•ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
MHC II-restricted neoantigenç–«è‹—æˆåŠŸé€†è½¬å†·è‚¿ç˜¤çš„å…ç–«å¾®ç¯å¢ƒï¼Œå…‹æœå¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚ï¼ˆICIsï¼‰çš„è€è¯æ€§ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤å…ç–«æ²»ç–—</strong>ï¼šæ¢ç´¢æ–°å‹ç–«è‹—ï¼ˆMHC II-restricted neoantigenç–«è‹—ï¼‰å’Œè¯ç‰©ï¼ˆHER3-DXdï¼‰åœ¨å†·è‚¿ç˜¤å’Œå®ä½“ç˜¤ä¸­çš„ç–—æ•ˆåŠè€è¯æœºåˆ¶ã€‚</li><li><strong>è‚¿ç˜¤å¾®ç¯å¢ƒä¸åŸºå› è°ƒæ§</strong>ï¼šè§£æèƒ¶åŸè›‹ç™½æ’åˆ—ã€RNAåœ¨æŸ“è‰²è´¨è°ƒæ§ä¸­çš„ä½œç”¨ã€è½¬åº§å­è°ƒæ§å…ƒä»¶çš„ç»„ç»‡ç‰¹å¼‚æ€§é™åˆ¶ï¼Œä»¥åŠCDK9åœ¨Tç»†èƒæ·‹å·´ç˜¤ä¸­çš„ä¾èµ–æ€§ã€‚</li><li><strong>ç™Œç—‡ä»£è°¢ä¸ä¿¡å·é€šè·¯</strong>ï¼šç ”ç©¶ç³–é…µè§£å¼‚è´¨æ€§é©±åŠ¨çš„èƒ°è…ºç™Œï¼ˆPDACï¼‰ä»£è°¢é¶å‘æ²»ç–—ï¼Œä»¥åŠé“œæŠ‘åˆ¶ATRä¸PARPæŠ‘åˆ¶å‰‚ååŒæŠ—ç™Œçš„æœºåˆ¶ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>ç©ºé—´è½¬å½•ç»„å­¦</strong>ï¼šç»“åˆèƒ¶åŸè›‹ç™½åˆ†æï¼ˆCASTAï¼‰æ­ç¤ºç»“ç›´è‚ ç™Œä¸­çš„åŸºå› ç¨‹åºã€‚</li><li><strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šåˆ©ç”¨RNA-seqã€ATAC-seqã€ChIP-seqã€CLAP-seqã€scRNA-seqç­‰æŠ€æœ¯æ·±å…¥ç ”ç©¶åŸºå› è¡¨è¾¾ã€æŸ“è‰²è´¨å¯åŠæ€§åŠè›‹ç™½ç»“åˆã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ–°å—å¨å°”å£«å·ï¼ˆNSWï¼‰å°†æ¶ˆé˜²å‘˜çš„ç™Œç—‡ä¿é™©è¦†ç›–èŒƒå›´æ‰©å¤§è‡³åŒ…æ‹¬æ›´å¤šç§ç±»çš„ç™Œç—‡ï¼Œè¿™æ˜¯å¯¹æ¶ˆé˜²å‘˜å¥åº·ä¿éšœçš„ä¸€é¡¹é‡å¤§è¿›å±•ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ‰©å¤§ç‰¹å®šèŒä¸šæš´éœ²ç›¸å…³ç™Œç—‡çš„ä¿é™©èŒƒå›´ã€‚</li><li>æå‡æ¶ˆé˜²å‘˜å› å·¥æ‚£ç™Œçš„ç»æµå’ŒåŒ»ç–—æ”¯æŒã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>åŸºäºæµè¡Œç—…å­¦æ•°æ®å’ŒèŒä¸šé£é™©è¯„ä¼°ï¼Œé‡æ–°ç•Œå®šäº†ä¿é™©è¦†ç›–çš„ç™Œç—‡åˆ—è¡¨ã€‚</li><li>æ”¿ç­–è°ƒæ•´æ—¨åœ¨è§£å†³æ¶ˆé˜²å‘˜èŒä¸šå¥åº·é£é™©çš„é•¿æœŸæ€§é—®é¢˜ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é¦–æ¬¡å‘ç°è¡€æ¶²ç»†èŒäº§ç”Ÿçš„æ–°å‹åˆ†å­å…·æœ‰æ˜¾è‘—æŠ—è¡°è€æ½œåŠ›ï¼Œèƒ½æœ‰æ•ˆæŠ‘åˆ¶ç‚ç—‡ã€æ°§åŒ–åº”æ¿€å’Œèƒ¶åŸè›‹ç™½é™è§£ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è¯†åˆ«å’Œè¡¨å¾è¡€æ¶²ç»†èŒäº§ç”Ÿçš„æŠ—è¡°è€ä»£è°¢ç‰©ã€‚</li><li>è¯„ä¼°è¿™äº›åˆ†å­åœ¨æŠ‘åˆ¶è¡°è€ç›¸å…³ç‚ç—‡å’Œæ°§åŒ–åº”æ¿€ä¸­çš„ä½œç”¨ã€‚</li><li>æ¢ç´¢å…¶ä¿æŠ¤èƒ¶åŸè›‹ç™½å…å—æŸä¼¤çš„æœºåˆ¶ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>é‰´å®šå‡ºä¸€ç§æ–°å‹çš„ã€æ­¤å‰ç ”ç©¶ç”šå°‘çš„è¡€æ¶²ç»†èŒã€‚</li><li>å‘ç°å…¶äº§ç”Ÿçš„å²å“šç±»ä»£è°¢ç‰©å…·æœ‰å¤šé‡æŠ—è¡°è€æ´»æ€§ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (35æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>Cancer Immunol Immunother | 2025å¹´ä¾æ—§å¯ç”¨çš„5+è‚¿ç˜¤ç”Ÿä¿¡æ€è·¯ï¼šé¢„å+å•ç»†èƒ+bulk+å®éªŒéªŒè¯</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€cancerã€Tç»†èƒã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè¡°è€æ˜¯èƒ¶è´¨æ¯ç»†èƒç˜¤ï¼ˆGBMï¼‰æ‚£è€…ä¸è‰¯é¢„åçš„ä¸€ä¸ªå…¬è®¤é£é™©å› ç´ ï¼Œå¹¶ä¸”åŠæ•°ä»¥ä¸Šçš„GBMæ‚£è€…æ˜¯è€å¹´äººï¼Œä½†æ˜¯ç›®å‰å¯¹äºå¹´é¾„</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248976&amp;idx=1&amp;sn=0b9f66fbabeacd3de17204ecb2a0be7a">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>STTTï¼šå¸®ç™Œç»†èƒæ”¶æ•›â€œå…‰èŠ’â€ï¼å¤æ—¦å¤§å­¦/åŒæµå¤§å­¦ç­‰å›¢é˜Ÿå‘ç°ï¼ŒFAM114A1æ˜¯ä¸‰é˜´æ€§ä¹³è…ºç™Œå…ç–«é€ƒé€¸å’Œå¯¹å…ç–«æ²»ç–—è€è¯çš„å…³é”®å› å­</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå¥‡ç‚¹è‚¿ç˜¤æ¢ç§˜</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒã€ç»†èƒå› å­ã€è€è¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šå…¬å¸ƒä¸‰é˜´æ€§ä¹³è…ºç™Œçš„éšèº«ç§˜è¯€ï¼</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503632&amp;idx=1&amp;sn=553cfcb3aaa6013f4edf1f70ea14d90b">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>ç©ºé—´å¤šç»„å­¦æ­ç¤ºç»“ç›´è‚ ç™Œä¸­C1QC+å·¨å™¬ç»†èƒ-CD4+ Tç»†èƒç”Ÿæ€ä½åŠå…¶å¯¹å…ç–«æ²»ç–—çš„å¯ç¤º</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šäººä½“è›‹ç™½è´¨ç»„å¯¼èˆªè®¡åˆ’</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒã€å·¨å™¬ç»†èƒã€ç©ºé—´ç»„å­¦</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507767&amp;idx=1&amp;sn=0fbbe3fba6195da3f82f357f9376449d">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>AMLç»†èƒå¤šç»„å­¦åˆ†æå¹¶æ­ç¤ºè¡¨è§‚åŸºå› ç»„æœºåˆ¶é©±åŠ¨è¯ç‰©è€è¯æ€§çš„äº§ç”Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯ã€åŸºå› ç»„ã€è¡¨è§‚åŸºå› ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè¡€æ¶²è‚¿ç˜¤AMLè¿›è¡Œå¤šç»„å­¦åˆ†æè¯„ä¼°åŒ–ç–—è€è¯æ–°æœºåˆ¶ï¼Œç¡®å®šè¡¨è§‚é—ä¼ é‡ç¼–ç¨‹è€ŒéåŸºå› çªå˜æ˜¯è€è¯æ€§äº§ç”Ÿçš„ä¸»è¦é©±åŠ¨åŠ›ã€‚å»ç”²åŸºåŒ–è¯ç‰©å¯è¯±å¯¼ç»†èƒå‘æ›´åŸå§‹çŠ¶æ€é€†è½¬ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247534063&amp;idx=1&amp;sn=ab2004c0c7d85e1d99cb287e2eaa5502">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>8+å¹²æ¹¿ç»“åˆæ¨¡æ¿æ–‡ç« ï¼Œç»“åˆåˆ†å‹å’Œå»ºæ¨¡è¯†åˆ«è„‚è´¨ä»£è°¢å…³é”®åŸºå› ï¼Œè¿›å±•å¢æ®–ï¼Œå‡‹äº¡ï¼Œä»£è°¢å’Œå…ç–«å¾®ç¯å¢ƒçš„å®éªŒéªŒè¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€ä»£è°¢</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504134&amp;idx=6&amp;sn=4ea8f84ee8fde511c42be4a03126f405">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>æœ€æ–°14+å¹²æ¹¿ç»“åˆSCIï¼Œä½œè€…é‰´å®šå‡ºå¹²æ‰°ç´ è¯±å¯¼çš„è¡°è€ CD8T ç»†èƒå¹¶æ­ç¤ºå…¶å¯¹å…ç–«æ²»ç–—çš„å½±å“ã€‚è¡°è€è™½è€ï¼Œä½†æ˜¯çœŸçš„ç«ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€è¡°è€ã€Tç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504134&amp;idx=4&amp;sn=b3501612bf2bb9ead6b5268594e2a367">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>10.6åˆ†éè‚¿ç˜¤å¹²æ¹¿ç»“åˆç”Ÿä¿¡ï¼Œé¶å‘ CD177 + ä¸­æ€§ç²’ç»†èƒå‡è½»ç¼ºè¡€å†çŒæ³¨æŸä¼¤ã€‚é€‚åˆåŠ¨ç‰©å»ºæ¨¡æµ‹åºæ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€æµ‹åºã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504134&amp;idx=3&amp;sn=f8d0517f9fe8929b6904909e4c0fb64d">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>å•ç»†èƒ+ç©ºè½¬+ä»£è°¢ç»„ï¼Œå…¬å¼€æ•°æ®é›†æ‰¾å‡ºäº®ç‚¹å°±èƒ½å‘1åŒº12åˆ†</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€ä»£è°¢ç»„ã€å•ç»†èƒ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248976&amp;idx=4&amp;sn=0576c1aaee3516acf4d81fa0536758b8">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>å›½å®¶ç§‘æŠ€é‡å¤§ä¸“é¡¹å°±æ”¯æŒé™¢å£«è¯¾é¢˜ç»„åšä¸€ä¸ªtcgaä»»æ„ç™Œç—‡çš„è½¬å½•ç»„å·®å¼‚åˆ†æå—ï¼Ÿï¼ˆé¥¶æ¯…éƒ½æ‡’å¾—æ€¼è¿™äº›ï¼‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡æŠ€èƒ½æ ‘</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€è½¬å½•ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè®©æˆ‘æœ‰ç‚¹çº³é—·ï¼šå›½å®¶ç§‘æŠ€é‡å¤§ä¸“é¡¹å°±æ”¯æŒé™¢å£«è¯¾é¢˜ç»„åšä¸€ä¸ªtcgaä»»æ„ç™Œç—‡çš„è½¬å½•ç»„å·®å¼‚åˆ†æå—ï¼Ÿ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247547266&amp;idx=1&amp;sn=7ae51a2a7700df86e8e82d1817078771">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>æœ€æ–°11+ç”Ÿä¿¡ï¼Œèšç„¦åŸºè´¨ç»†èƒ-å…ç–«ç»†èƒçš„äº’ä½œç½‘ç»œã€‚æœ¬æ–‡å®éªŒå®Œç¾è¯å®ç”Ÿä¿¡ç»“æœï¼Œå¹²æ¹¿ç»“åˆæ°åˆ°å¥½å¤„ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€ç”Ÿä¿¡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493052&amp;idx=1&amp;sn=301427e4041c0565adff83aed89c5625">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 25 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (36æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE275680 MHC II é™åˆ¶æ€§æ–°æŠ—åŸç–«è‹—é€†è½¬å…ç–«å¾®ç¯å¢ƒå¹¶å…‹æœå†·è‚¿ç˜¤å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„è€è¯æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€vaccineã€MHCã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xueru Song ; Chun LuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusCold tumors are resistant to immune checkpoint inhibitors (ICIs) due to their poor T cell infiltration and immunosuppressive tumor microenvironment (TME). While the role of CD4+ T cell response in anti-tumor immunity has been emphasized, it remains unclear whether the MHC II-restricted neoantigen vaccines targeting CD4+ T cell can reverse the immune microenvironment and overcome resistance to ICIs. Here we observed an enrichment of immune inflammation-related signaling pathways in TME following administration of MHC II-restricted neoantigen vaccines, indicating their potent role in reversing immunosuppressive TME. An increase in the tumor infiltration of CD4+ T cells and CD8+ T cells, an enhancement of their effector functions, and a tendency towards exhaustion were observed, providing prerequisites for the effectiveness of ICI treatment. Furthermore, NicheNet analysis indicated an enrichment of the inhibitory immune checkpoint signaling axis PVR-TIGIT following vaccination. The combination of the vaccines and TIGIT blockade exhibited synergistic anti-tumor efficacy. Mechanistically, the combination therapy promoted the differentiation of CD8+ T cells into effector memory phenotypes while delaying their exhaustion. Our study demonstrates that MHC II-restricted neoantigen vaccines can remodel the inhibitory TME with insufficient T cell infiltration and synergistically inhibit tumor growth with TIGIT antibody, providing a novel strategy for treating cold tumors.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275680">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE311294 èƒ¶åŸè›‹ç™½æ’åˆ—å’Œç©ºé—´è½¬å½•ç»„å­¦åˆ†æ (CASTA) æ­ç¤ºäº†ä¸ç»“ç›´è‚ ç™Œä¸­èƒ¶åŸè›‹ç™½æ’åˆ—ç›¸å…³çš„åŸºå› ç¨‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€spatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Maxwell Hamilton ; Alan Simmons ; Harsimran Kaur ; Samuel Ellis ; Ken Lau ; Robert CoffeySeries Type : OtherOrganism : Homo sapiensThe use of immune checkpoint blockade is limited to the minority of colorectal cancers that are highly infiltrated by CD8+ T cells. Therefore, a method to improve CD8+ T-cell infiltration has the potential to expand the use immune checkpoint blockade to more patients. Barriers of aligned collagen surrounding tumors have been proposed as one mechanisim of CD8+ T-cell exclusion. We use 5 colorectal cancer patient samples to examine the relationship between collagen alignment and gene expression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311294">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE299573 è†€èƒ±ç™Œé³çŠ¶åˆ†åŒ–çš„ç©ºé—´è½¬å½•ç»„å­¦</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€spatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ryuta Watanabe ; Shunsuke Haga ; Noriyoshi Miura ; Tadahiko Kikugawa ; Takashi SaikaSeries Type : OtherOrganism : Homo sapiensWe analyze the gene expression of bladder cancer with squamous differenciarion using spatial gene expression analysis techniques (Visium HD, 10x genomics).</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299573">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE275679 RNAæµ‹åºï¼Œåˆ†æäº†ç”¨ç”Ÿç†ç›æ°´æˆ–M44ç–«è‹—æ²»ç–—çš„B16F10è·ç˜¤å°é¼ çš„æ–°é²œè‚¿ç˜¤ç»„ç»‡ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€vaccineã€sequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xueru Song ; Chun LuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo further reveal the immune regulatory effects of MHC II-restricted vaccines on TME, bulk RNA sequencing (bulk RNA-seq) was performed to analyze the overall immune signal transformation. Differential gene expression analysis recognized a total of 1695 upregulated and 343 downregulated genes on the M44 vaccination. Specifically, a higher expression of CD74, H2-Ab1, H2-Eb1, H2-Aa was observed in the vaccinated group, indicating the active MHC class II antigen processing and presentation in tumors. The ssGSEA method was used to quantify RNA-seq data of each sample and the GO_BP (Biological Process of Gene Ontology) term scores were calculated. The results indicated that the majority of the terms within high ssGSEA scores were related to both adaptive and innate immune-related processes.We then sorted the top 300 differently upregulated genes to generated pathway enrichment analysis and clustered the pathways into 20 categories based on functional relevance. Interestingly, the majority of categories were related to the activation of antitumor immune response, such as â€œinflammatory responseâ€ â€œleukocyte activationâ€ â€œantigen processing and presentationâ€ â€œleukocyte migrationâ€ and â€œphagocytosisâ€. Moreover, immune infiltration estimations showed increased infiltration levels of T cells, CD8+ T cells, NK cells, memory B cells and monocytes/macrophages.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275679">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>GSE300421 RNA ä¿ƒè¿›æŸ“è‰²è´¨ç›¸å…³å‡èšä½“çš„æˆæ ¸å’Œè‡´ç™Œæ´»æ€§ [ChIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:onco(logy|logist|gene|genic)ã€ChIP-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Krista A Budinich ; Xinyi Yao ; Chujie Gong ; Lele Song ; Michelle C Lee ; Qinglan Li ; Sylvia Tang ; Kaeli M Mathias ; Yiman Liu ; Son C Nguyen ; Eric F Joyce ; Yuanyuan Li ; Haitao Li ; Liling WanSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensAberrant chromatin-associated condensates have emerged as drivers of gene dysregulation in cancer, yet the mechanisms regulating their formation and function remain poorly understood. Mutations in the histone acetylation reader ENL, recurrent in leukemia and Wilms tumor, drive oncogenesis by inducing condensate formation at selective target loci. Here, we show that RNA promotes the nucleation, chromatin engagement, and oncogenic activity of ENL mutant condensates. Mutant ENL binds RNA via a conserved basic patch within the YEATS domain, and this interaction enhances condensate formation in vitro and in cells. Acute displacement and reassembly experiments demonstrate that interactions with local RNA transcripts facilitate condensate nucleation efficiency at endogenous target loci. Partial disruption of RNA binding preferentially impairs chromatin occupancy of ENL mutants at condensate-permissive loci, leading to reduced transcriptional bursting and target gene expression. In mouse models, disrupting RNA binding compromises mutant ENL-driven gene expression and malignant self-renewal, halting disease progression and prolonging survival. These findings uncover a previously unrecognized role of RNA in promoting the formation and oncogenic function of chromatin-associated condensate.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300421">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GSE300418 RNA ä¿ƒè¿›æŸ“è‰²è´¨ç›¸å…³å‡èšä½“çš„æˆæ ¸å’Œè‡´ç™Œæ´»æ€§ [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:onco(logy|logist|gene|genic)ã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Krista A Budinich ; Xinyi Yao ; Chujie Gong ; Lele Song ; Michelle C Lee ; Qinglan Li ; Sylvia Tang ; Kaeli M Mathias ; Yiman Liu ; Son C Nguyen ; Eric F Joyce ; Yuanyuan Li ; Haitao Li ; Liling WanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Mus musculusAberrant chromatin-associated condensates have emerged as drivers of gene dysregulation in cancer, yet the mechanisms regulating their formation and function remain poorly understood. Mutations in the histone acetylation reader ENL, recurrent in leukemia and Wilms tumor, drive oncogenesis by inducing condensate formation at selective target loci. Here, we show that RNA promotes the nucleation, chromatin engagement, and oncogenic activity of ENL mutant condensates. Mutant ENL binds RNA via a conserved basic patch within the YEATS domain, and this interaction enhances condensate formation in vitro and in cells. Acute displacement and reassembly experiments demonstrate that interactions with local RNA transcripts facilitate condensate nucleation efficiency at endogenous target loci. Partial disruption of RNA binding preferentially impairs chromatin occupancy of ENL mutants at condensate-permissive loci, leading to reduced transcriptional bursting and target gene expression. In mouse models, disrupting RNA binding compromises mutant ENL-driven gene expression and malignant self-renewal, halting disease progression and prolonging survival. These findings uncover a previously unrecognized role of RNA in promoting the formation and oncogenic function of chromatin-associated condensate.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300418">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE291608 å‰ªæ¥å¼‚æ„ä½“æ‰°åŠ¨ä¸å•ç»†èƒè½¬å½•ç»„åˆ†æç›¸ç»“åˆæ­ç¤ºäº†å¾®å¤–æ˜¾å­åœ¨ç¥ç»å‘ç”Ÿå’Œè‡ªé—­ç—‡ç›¸å…³é€šè·¯ä¸­çš„åŠŸèƒ½ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€transcriptome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Steven Dupas ; Guillermo Parada ; Jack Diayang Li ; Kevin Brown ; Jason Moffat ; Benjamin BlencoweSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusA major challenge of biomedical research is to assign functions to the myriad alternative RNA and protein isoforms. This challenge is particularly relevant to the mammalian nervous system, which produces complex repertoires of alternative splicing events. Here, we describe CHyMErA-seq, a platform that couples systematic deletion of exons to a single cell transcriptomics read-out, and apply this method to investigate a critical program of brain-specific microexons. Perturbation of microexons during neurogenesis reveals convergent roles in the temporal regulation of gene expression programs that direct signalling pathways and morphogenesis. We further observe microexons, including those in the Bin1, Clasp1, Gfra1, Med23, Ptprf and Ralgapb genes, that are required for the correct timing of autism-linked gene expression. Collectively, we describe a flexible system for isoform-resolution perturbation at a single cell level, together with insights into the roles of microexons in the developmental timing of neurogenesis transcriptomic signatures linked to brain disorders.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291608">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE311464 è„‘ç™Œæ‚£è€…ä½“å†…ä»£è°¢é€šé‡ä¼°ç®—çš„æ•°å­—å­ªç”Ÿæ¨¡å‹ II</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€metabolic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Baharan Meghdadi ; Wajd N. Al-Holou ; Andrew J. Scott ; Anjali Mittal ; Ningning Liang ; Sravya Palavalasa ; Abhinav Achreja ; Alexandra O&rsquo;Brien ; Kathy Do ; Zhe Wu ; Jiane Feng ; Nathan R. Qi ; Vijay Tarnal ; Sriram Venneti ; C. Ryan Miller ; Jann N. Sarkaria ; Weihua Zhou ; Theodore S. Lawrence ; Costas A. Lyssiotis ; Daniel R. Wahl ; Deepak NagrathSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Mus musculusRecent advancements in metabolic flux estimations in vivo are limited to preclinical models, primarily due to challenges in tissue sampling, tumor microenvironment heterogeneity, and non-steady state conditions. To address these limitations and enable flux estimation in human patients, we developed two machine learning-based frameworks. First, the digital twin framework integrates first-principles stoichiometric and isotopic simulations with convolutional neural networks to estimate fluxes in patient bulk samples. Second, the 13C-scMFA framework combines patient scRNA-seq data with 13C-isotope tracing, allowing single-cell-level flux quantification. These studies allow quantification of metabolic activity in neoplastic glioma cells, revealing frequently elevated purine synthesis and serine uptake compared to non-malignant cells. Our models also identify metabolic heterogeneity among patients and mice with brain cancer, in turn predicting treatment responses to metabolic inhibitors. Our frameworks advance in vivo metabolic flux analysis, may lead to novel metabolic therapies, and identify biomarkers for metabolism-directed therapies in patients.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311464">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE311441 äº¤æ„Ÿç¥ç»å…ƒè¿‡åº¦æ¿€æ´»é©±åŠ¨æ¯›å›Šåæ­»å’Œ T ç»†èƒè‡ªèº«ååº”æ€§ [scRNA]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Emily Scott-Solomon ; Shlomi Brielle ; Ya-Chieh HsuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusStress profoundly affects health, but the mechanisms driving stress-induced tissue changes remain poorly understood. Here, we show that strong acute stress drives rapid hair loss and initiates autoimmunity. Under stress, hyperactivated sympathetic nerves release excessive norepinephrine, causing necrosis in rapidly dividing hair follicle transit-amplifying cells (HF-TACs) while sparing most hair follicle stem cells (HFSCs). This differential sensitivity to stress stems from differences in cell death genes, metabolic strategies, and calcium homeostasis. Together, these factors render HF-TACs more vulnerable to the sudden calcium surges triggered by norepinephrine. HF-TAC necrosis releases cellular debris that triggers macrophage clearance and dendritic cell activation, ultimately leading to the activation and amplification of autoreactive T cells that can attack the hair follicle. Our findings reveal mechanistically how stress causes immediate tissue damage in the highly proliferative HF-TACs via sympathetic nerve-induced necrosis, which in turn fuels the activation of a T cell-mediated response against the hair follicle.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311441">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE308506 å¤–æ˜¾å­6æˆªçŸ­çš„p53æŠ‘åˆ¶å…ˆå¤©å…ç–«ååº”ï¼Œä»è€Œä¿ƒè¿›è†€èƒ±ç™Œçš„å…ç–«é€ƒé€¸</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immune</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Chi ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPrevious studies have reported that truncated p53 exhibits pro-tumorigenic properties; however, whether it contributes to immune evasion by influencing the immune microenvironment remains unclear.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308506">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 26 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>æ–°å—å¨å°”å£«å·æ‰©å¤§æ¶ˆé˜²å‘˜çš„ç™Œç—‡ä¿é™©è¦†ç›–èŒƒå›´</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1994573631349436416/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>éšè—çš„è¡€æ¶²åˆ†å­å±•ç°å‡ºæƒŠäººçš„æŠ—è¡°è€èƒ½åŠ›</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šaging</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šScientists have identified new anti-aging compounds produced by a little-studied blood bacterium. These indole metabolites were able to reduce inflammation, oxidative stress, and collagen-damaging activity in skin cell cultures. Three of the compounds, including two never seen before, showed particularly strong effects. The findings hint at a surprising new source for future skin-rejuvenation therapies.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251128050514.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>cancer</td><td>10</td></tr><tr><td>å…ç–«</td><td>8</td></tr><tr><td>RNA-seq</td><td>7</td></tr><tr><td>è‚¿ç˜¤</td><td>6</td></tr><tr><td>ç”Ÿä¿¡</td><td>5</td></tr><tr><td>ä»£è°¢</td><td>5</td></tr><tr><td>Tç»†èƒ</td><td>5</td></tr><tr><td>è€è¯</td><td>4</td></tr><tr><td>å•ç»†èƒ</td><td>4</td></tr><tr><td>tumor</td><td>4</td></tr><tr><td>ç™Œç—‡</td><td>3</td></tr><tr><td>åŸºå› ç»„</td><td>3</td></tr><tr><td>ATAC-seq</td><td>3</td></tr><tr><td>regex:onco(logy</td><td>logist</td></tr><tr><td>immune</td><td>3</td></tr><tr><td>çº¿ç²’ä½“</td><td>3</td></tr><tr><td>å·¨å™¬ç»†èƒ</td><td>2</td></tr><tr><td>è¡°è€</td><td>2</td></tr><tr><td>æµ‹åº</td><td>2</td></tr><tr><td>metabolic</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (25æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504134&amp;idx=2&amp;sn=5e9d3996b20ba57304352ebb9ce18a05">æœ€æ–°11+ç”Ÿä¿¡ï¼Œèšç„¦åŸºè´¨ç»†èƒ-å…ç–«ç»†èƒçš„äº’ä½œç½‘ç»œã€‚æœ¬æ–‡å®éªŒå®Œç¾è¯å®ç”Ÿä¿¡ç»“æœï¼Œå¹²æ¹¿ç»“åˆæ°åˆ°å¥½å¤„ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504134&amp;idx=1&amp;sn=6fc509060e55c0a3f474d3e12d0670df">æœ€æ–°10+ç”Ÿä¿¡ï¼Œè¯†åˆ«DPP7+TAMsï¼Œå‘ˆç°M2æåŒ–è¡¨å‹ï¼Œæ¥ç€è¿›è¡Œå®éªŒéªŒè¯ï¼é¶å‘åŸºå› å¢åŠ å…ç–«æ²»ç–—ç–—æ•ˆã€‚ç»å…¸å¹²æ¹¿ç»“åˆæ€è·¯ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503149&amp;idx=1&amp;sn=753042e3e87321055356e9d3b3b7930e">GWAS | Nat.Genet. | æ³›è‹±å›½ç”Ÿç‰©æ ·æœ¬åº“å…¨åŸºå› ç»„å…³è”åˆ†æå¢å¼ºäº†å¯¹ç¥–å…ˆå¯Œé›†æ•ˆåº”çš„å‘ç°ä¸è§£æèƒ½åŠ›</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507767&amp;idx=2&amp;sn=800170df90e8b9404ecf5189af0397dd">Nature | é‡å¡‘è‚¿ç˜¤æ¼”åŒ–æ¨¡å‹ï¼šé«˜è¾¾ 40% çš„å®¶æ—æ€§è…ºç˜¤æ€§æ¯è‚‰ç—…ï¼ˆFAPï¼‰ç™Œå‰ç—…å˜æºäºå¤šç»†èƒè°±ç³»ååŒ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkyNDI1MzE0NA==&amp;mid=2247490210&amp;idx=1&amp;sn=7d397ff4b37f9f4af10c5d5afaf87590">å•ç»†èƒRNAæµ‹åºçš„å¤§è§„æ¨¡åŸºå‡†æµ‹è¯•åˆ†æ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248976&amp;idx=6&amp;sn=4f2174cc605f2080465db4d378120df9">Scienceæ–°å‘ç°ï¼šé¶å‘â€œè‚¿ç˜¤é…¸ä¸­æ¯’â€ï¼Œæœ‰æœ›ç ´è§£æ²»ç–—è€è¯éš¾é¢˜ï¼è¿™3ä¸ªé¶ç‚¹å€¼å¾—å…³æ³¨</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247651034&amp;idx=3&amp;sn=a1994ee5088d59f6138538e4fbc5429d">æ­¦æ±‰å¤§å­¦å‘¨è£å®¶å›¢é˜Ÿï¼šæ­ç¤ºçº¿ç²’ä½“ NAD+ è°ƒæ§çº¿ç²’ä½“è‡ªå™¬åŠç‚ç—‡ååº”çš„æ–°æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzMzY5NDk3NA==&amp;mid=2247493579&amp;idx=1&amp;sn=86bde006839fef8feaa47edde87e9d54">è‚ é“é‡Œçš„â€œéšå½¢å†…é¬¼â€ï¼šNatureå­åˆŠæ­ç§˜550ç§ç»†èŒé…¶å¦‚ä½•â€œå¤æ´»â€è‡´ç™Œæ¯’ç´ ï¼ŒåŠ é€Ÿè‚ ç™Œæ¶åŒ–ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247791008&amp;idx=3&amp;sn=c1330af4361f191988b31a125cb6bae6">åˆ˜å…‰æ…§å›¢é˜Ÿå»ºç«‹è¡€ç®¡å’Œç¥ç»ç±»å™¨å®˜æ¨¡å‹ï¼Œæ­ç¤ºäººç±»è¡°è€ä¸ç–¾ç—…æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247791008&amp;idx=1&amp;sn=fce45123076c1cc48b67a868ed5a2981">ä¸­å›½åšåä¸€ä½œCellè®ºæ–‡ï¼šå‘ç°å…¨æ–°ç»†èƒæ­»äº¡æ–¹å¼â€”â€”Mitoxyperilysisï¼Œç”±çº¿ç²’ä½“æ°§åŒ–é©±åŠ¨ï¼Œå¯ç”¨äºç™Œç—‡æ²»ç–—</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247538330&amp;idx=1&amp;sn=81e25cd5e689688ca70b11b4dc7a1524">åŸºäºæ·±åº¦å­¦ä¹ çš„å•ç»†èƒæ•´åˆæ–¹æ³•çš„åŸºå‡†ç ”ç©¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484123&amp;idx=1&amp;sn=fc15ecb0d3cd1611a3b4e4dcafb9e4ce">ç»´ç”Ÿç´ Dä½“å†…ä»£è°¢è¿‡ç¨‹ï¼ˆå»ºè®®æ”¶è—ï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkyNzcxMjEyMg==&amp;mid=2247498087&amp;idx=1&amp;sn=ca6d5718d6ca7c40bc99386f0d1e3ec7">è¿™ç¯‡çš„èªæ˜ä¹‹å¤„é€‚åˆå­¦ï¼é â€œTFAM-æ ¸å¿ƒåŸºå› -é€šè·¯â€è½´æ­æ¡†æ¶ï¼Œå°±èƒ½å¿«é€Ÿç§¯ç´¯å›½è‡ªç„¶å‰æœŸæ•°æ®ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkyNzcxMjEyMg==&amp;mid=2247498125&amp;idx=1&amp;sn=664cdf46c01722b58630b1e9e8ded939">è°è¿˜åœ¨æ‰¾å·¨å™¬ç»†èƒæ–°æ€è·¯ï¼ŸIF:10.1å¹¿å·å¤§å­¦å‘ç°PGE2-EP4-C/EBPÎ²æ­£åé¦ˆå›è·¯</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504134&amp;idx=5&amp;sn=37c1d55952c0061de6e8def2fae00045">æ°¨åŸºé…¸ä»£è°¢æ˜¯çœŸçš„ç«ï¼Œå¹²æ¹¿ç»“åˆè½»æ¾å‘7.5åˆ†2åŒºæ–‡ç« ã€‚ç°åœ¨ä¸‹æ‰‹è¿˜ä¸æ™šï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzk3NTY2NDk1Nw==&amp;mid=2247488385&amp;idx=3&amp;sn=550caca700ce0cd0ed2487e919aebcc8">æ–©è·157é¡¹èµ„åŠ©çš„DNAç”²åŸºåŒ–ï¼šæœºåˆ¶å¥—è·¯è§£æï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503149&amp;idx=2&amp;sn=99c18a89b3f662b8ecf9c14a8ba9c7ed">åŸºå› ç»„ | Nature | åŸºäºå››ä»£å®¶ç³»å‚è€ƒçš„äººç±»æ–°ç”Ÿçªå˜ç‡</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248976&amp;idx=5&amp;sn=70016cf9dd0fb45085d35d7933e102f0">é›†æˆæœºå™¨å­¦ä¹ æ‰“é€šè‚¿ç˜¤é¢„åæ¨¡å‹çš„â€œæœ€åä¸€å…¬é‡Œâ€&mdash;-2025å¤šé¡¹ç ”ç©¶æ·±åº¦è§£æ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248976&amp;idx=2&amp;sn=a310f32ca452eab51495da301b50353f">èƒ†ç®¡ç™Œæ²»ç–—é‡å¤§çªç ´ï¼šé¶å‘PARGè°ƒæ§Hippoï¼ŒåŒ–ç–—ã€å…ç–«åŒå¢æ•ˆ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656511123&amp;idx=3&amp;sn=dd1fccb9836762853795088ad290f940">æŠ‘åˆ¶è‡ªå™¬ï¼å—äº¬ä¸­åŒ»è¯å¤§å­¦/å“ˆå°”æ»¨åŒ»ç§‘å¤§å­¦é™„å±è‚¿ç˜¤åŒ»é™¢åˆä½œå‘æ–‡ï¼šä¹³è…ºç™Œæ²»ç–—æ–°æ–¹æ³•</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656511123&amp;idx=1&amp;sn=9f0ae70ea9742424557473005bbb49c1">çªç ´æŠ€æœ¯ç“¶é¢ˆï¼ä¸­ç§‘é™¢å¶æ˜äº®å›¢é˜Ÿå¼€å‘æ–°å‹è›‹ç™½è´¨ç»„å­¦æ–¹æ³•é¦–æ¬¡åœ¨æ´»ç»†èƒä¸­åŸä½ã€é«˜é€šé‡åœ°è§£æè¯ç‰©ä½œç”¨æ—©æœŸåˆ†å­äº‹ä»¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzMzY5NDk3NA==&amp;mid=2247493603&amp;idx=1&amp;sn=11c96e6abde077c0b56d8d625a848c46">Cellé‡ç£…å®šä¹‰ï¼2025å¹´é¦–ä¸ªæ–°å‹ç»†èƒæ­»äº¡æ–¹å¼â€œMitoxyperilysisâ€è¯ç”Ÿï¼šçº¿ç²’ä½“æ°§åŒ–å‘¨äº¡</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MjcxNzg1NA==&amp;mid=2247489040&amp;idx=2&amp;sn=b1320c7018df0408c89cd2aa6446a140">ç©ºé—´èšç±»åˆ†æä¹‹cellcharter</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247791008&amp;idx=2&amp;sn=047aba4f67576cf70e24da45a6fff22a">èµ«æ·é™¢å£«å›¢é˜Ÿè¯å®ï¼Œé“œæ­»äº¡å¯å…‹æœè‚ºç™Œé¶å‘æ²»ç–—è€è¯æ€§</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247490198&amp;idx=1&amp;sn=4feefaa6c1861236fdf5e724ee59f748">Nature Metabolismæ­ç¤ºèŠ³é¦™æ°¨åŸºé…¸ä»£è°¢ç‰©åœ¨é¢„é˜²è‚¥èƒ–ä¸­çš„å…³é”®ä½œç”¨</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (26æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303338">GSE303338 ç³–é…µè§£å¼‚è´¨æ€§é©±åŠ¨èƒ°è…ºç™Œä»£è°¢é¶å‘æ²»ç–—</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296515">GSE296515 A Natural Cyclic Peptide Enhances Cytotoxic Th9 Differentiation and Antitumor Immunity (ATACseq)</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295054">GSE295054 å¤©ç„¶ç¯çŠ¶è‚½å¢å¼ºç»†èƒæ¯’æ€§ Th9 åˆ†åŒ–å’ŒæŠ—è‚¿ç˜¤å…ç–«</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246085">GSE246085 é“œæŠ‘åˆ¶ ATR å¹¶ä¸ PARP æŠ‘åˆ¶å‰‚äº§ç”ŸååŒä½œç”¨ï¼ˆRNA-seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311829">GSE311829 AP-1 ä»‹å¯¼ç»†èƒé€‚åº”å’Œè®°å¿†å½¢æˆ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311827">GSE311827 AP-1 ä»‹å¯¼ç»†èƒé€‚åº”å’Œè®°å¿†å½¢æˆ [æ‰¹é‡ RNA æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311825">GSE311825 AP-1ä»‹å¯¼ç»†èƒé€‚åº”å’Œè®°å¿†å½¢æˆ[scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310423">GSE310423 ä¹³è…ºç™Œæ‚£è€…æ¥æºçš„å¼‚ç§ç§»æ¤ä¸­å¯¹å¸•å¦¥ç å•æŠ—å¾·é²æ›¿åº·ï¼ˆHER3-DXdï¼‰é•¿æœŸååº”çš„å†³å®šå› ç´ ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310422">GSE310422 ä¹³è…ºç™Œæ‚£è€…æ¥æºå¼‚ç§ç§»æ¤ä¸­å¸•å¦¥ç å•æŠ—å¾·é²æ›¿åº·ï¼ˆHER3-DXdï¼‰é•¿æœŸååº”çš„å†³å®šå› ç´  [NanoString]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307574">GSE307574 ä¹³è…ºç™Œæ‚£è€…æ¥æºå¼‚ç§ç§»æ¤æ¨¡å‹ä¸­å¸•å¦¥ç å•æŠ—å¾·é²æ›¿åº·ï¼ˆHER3-DXdï¼‰é•¿æœŸç–—æ•ˆçš„å†³å®šå› ç´ </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300420">GSE300420 RNA ä¿ƒè¿›æŸ“è‰²è´¨ç›¸å…³å‡èšä½“çš„æˆæ ¸å’Œè‡´ç™Œæ´»æ€§ [CLAP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298498">GSE298498 è½¬åº§å­è¡ç”Ÿè°ƒæ§å…ƒä»¶çš„ç»„ç»‡ç‰¹å¼‚æ€§é™åˆ¶ä¿æŠ¤ç»†èƒç±»å‹ç‰¹æ€§ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298495">GSE298495 è½¬åº§å­è¡ç”Ÿè°ƒæ§å…ƒä»¶çš„ç»„ç»‡ç‰¹å¼‚æ€§é™åˆ¶ä¿æŠ¤ç»†èƒç±»å‹ç‰¹æ€§ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296537">GSE296537 CDK9 æ˜¯ GATA-3 é©±åŠ¨å’Œ MCL-1 éä¾èµ–æ€§ T ç»†èƒæ·‹å·´ç˜¤çš„ä¾èµ–å› å­ [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296506">GSE296506 CDK9 æ˜¯ GATA-3 é©±åŠ¨å’Œ MCL-1 éä¾èµ–æ€§ T ç»†èƒæ·‹å·´ç˜¤çš„ä¾èµ–åŸºå›  [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291610">GSE291610 å‰ªæ¥å¼‚æ„ä½“æ‰°åŠ¨ç»“åˆå•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºå¾®å¤–æ˜¾å­åœ¨ç¥ç»å‘ç”Ÿå’Œè‡ªé—­ç—‡ç›¸å…³é€šè·¯ä¸­çš„åŠŸèƒ½ [snRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282088">GSE282088 å‰åˆ—è…ºç´  E2-EP2/EP4 ä¿¡å·è¯±å¯¼è‚¿ç˜¤æµ¸æ¶¦æ€§ Treg è¡¨å‹ä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿ [iTreg]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282087">GSE282087 å‰åˆ—è…ºç´  E2-EP2/EP4 ä¿¡å·ä¼ å¯¼è¯±å¯¼è‚¿ç˜¤æµ¸æ¶¦æ€§ Treg è¡¨å‹ä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿ [TITreg]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282086">GSE282086 å‰åˆ—è…ºç´  E2-EP2/EP4 ä¿¡å·ä¼ å¯¼è¯±å¯¼è‚¿ç˜¤æµ¸æ¶¦æ€§ Treg è¡¨å‹ä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿ [nTreg]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248839">GSE248839 çµé•¿ç±»åŠ¨ç‰©è¿›åŒ–è¿‡ç¨‹ä¸­ XIST è°ƒæ§ç½‘ç»œçš„å¹¿æ³›é‡å¡‘ [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248837">GSE248837 çµé•¿ç±»åŠ¨ç‰©è¿›åŒ–è¿‡ç¨‹ä¸­ XIST è°ƒæ§ç½‘ç»œçš„å¹¿æ³›é‡å¡‘ [Capture Hi-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246893">GSE246893 é“œæŠ‘åˆ¶ ATR å¹¶ä¸ PARP æŠ‘åˆ¶å‰‚äº§ç”ŸååŒä½œç”¨ï¼ˆDTP æ¨¡å‹ RNA-seq å’Œ Ola-ATRi-EC cGAS-STING RNA-seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311382">GSE311382 äººç±»å°èƒ¶è´¨ç»†èƒåœ¨ä½“å†…å¯¹Î²-æ·€ç²‰æ ·è›‹ç™½ã€tauè›‹ç™½ä»¥åŠé˜¿å°”èŒ¨æµ·é»˜ç—…ç—…ç†çš„è”åˆä½œç”¨è¡¨ç°å‡ºä¸åŒçš„ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311304">GSE311304 HIV Nef æ”¾å¤§æœºæ¢°å¼‚è´¨æ€§ä»¥ä¿ƒè¿›å…ç–«é€ƒé€¸</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311248">GSE311248 æ³›ç´ ç‰¹å¼‚æ€§è‚½é…¶32ç¨³å®šYAPå¹¶ä¿ƒè¿›ä¸‰é˜´æ€§ä¹³è…ºç™Œè¿›å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311236">GSE311236 è‚¥å¤§ç»†èƒ CRFR1 é€šè¿‡ MAPK/SPHK1 ä¿¡å·é€šè·¯ä¿ƒè¿›èƒ°è…ºç™Œç–¼ç—›</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-29 21:33</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week482025/ rel=tag>Week482025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-29/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-29</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-12-01/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-01</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-07/>ç§‘ç ”æ—¥æŠ¥ 2026-02-07</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-06/>ç§‘ç ”æ—¥æŠ¥ 2026-02-06</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-05/>ç§‘ç ”æ—¥æŠ¥ 2026-02-05</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-04/>ç§‘ç ”æ—¥æŠ¥ 2026-02-04</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-02/>ç§‘ç ”æ—¥æŠ¥ 2026-02-02</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (100)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (100)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>